Lifecore Biomedical, Inc.
LFCR
$6.10
-$0.085-1.38%
| 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | 11/26/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.25M | 6.54M | 12.01M | -20.19M | -72.33M |
| Total Depreciation and Amortization | 8.02M | 7.74M | 7.92M | 8.34M | 9.32M |
| Total Amortization of Deferred Charges | 500.00K | 500.00K | 500.00K | -- | -- |
| Total Other Non-Cash Items | 7.54M | -15.06M | -16.73M | 1.50M | 36.95M |
| Change in Net Operating Assets | -1.46M | 8.03M | -3.64M | -986.00K | 4.54M |
| Cash from Operations | 353.00K | 7.75M | 65.00K | -10.84M | -21.03M |
| Capital Expenditure | -14.75M | -16.54M | -18.20M | -22.74M | -23.59M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 1.01M | 13.54M |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.75M | -16.54M | -18.20M | -21.73M | -10.05M |
| Total Debt Issued | 149.52M | 149.22M | 149.59M | 181.19M | 173.52M |
| Total Debt Repaid | -158.83M | -147.63M | -147.42M | -151.61M | -178.50M |
| Issuance of Common Stock | 23.84M | 1.00K | 724.00K | 724.00K | 724.00K |
| Repurchase of Common Stock | -1.07M | -696.00K | -152.00K | -99.00K | -300.00K |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 38.08M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.17M | 4.77M | 4.77M | 2.50M | -6.05M |
| Cash from Financing | 20.63M | 5.67M | 7.51M | 32.69M | 27.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.23M | -3.12M | -10.63M | 123.00K | -3.61M |
